| 9902.07.10 |
Free |
|
2-(1,3-Benzothiazol-2-ylsulfanyl)succinic acid (CAS No. 95154-01-1) (provided for in subheading 2934.20.40) |
-- |
| 9902.07.11 |
Free |
|
4-Methylbenzothiazol-2-ylamine (CAS No. 1477-42-5) (provided for in subheading 2934.20.80) |
vs-99020710 |
| 9902.07.12 |
Free |
|
Zinc bis(1,3-benzothiazole-2-thiolate) (CAS No. 155-04-4) (provided for in subheading 2934.20.80) |
vs-99020711 |
| 9902.07.13 |
1.3% |
|
3-[2,4-Dichloro-5-(1-methylethoxy)phenyl]-5-(1,1-dimethyl- ethyl)-1,3,4-oxadiazol-2(3H)-one (Oxadiazon) (CAS No. 19666-30-9) (provided for in subheading 2934.99.11) |
vs-99020712 |
| 9902.07.14 |
4.6% |
|
1-({2-[2-Chloro-4-(4-chlorophenoxy)phenyl]-4-methyl-1,3- dioxolan-2-yl}methyl)-1H-1,2,4-triazole (Difenoconazole) (CAS No. 119446-68-3) (provided for in subheading 2934.99.12) |
vs-99020713 |
| 9902.07.15 |
5.0% |
|
4-(2,2-Difluoro-1,3-benzodioxol-4-yl)-1H-pyrrole-3-carbonitrile (Fludioxonil (ISO)) (CAS No. 131341-86-1) (provided for in subheading 2934.99.12) |
vs-99020714 |
| 9902.07.16 |
4.4% |
|
1-[[2-(2,4-Dichlorophenyl)-4-propyl-1,3-dioxolan-2-yl]- methyl]-1H-1,2,4-triazole (Propiconazole) (CAS No. 60207-90-1) (provided for in subheading 2934.99.12) |
vs-99020715 |
| 9902.07.17 |
Free |
|
2-Methyl-N-phenyl-5,6-dihydro-1,4-oxathiine-3-carboxamide (Carboxin) (CAS No. 5234-68-4) (provided for in subheading 2934.99.12)
|
vs-99020716 |
| 9902.07.18 |
Free |
|
2-Butyl-1,2-benzothiazol-3(2H)-one (CAS No. 4299-07-4) (provided for in subheading 2934.99.12) |
vs-99020717 |
| 9902.07.19 |
Free |
|
(2E)-3-(4-Chlorophenyl)-3-(3,4-dimethoxyphenyl)-1-(4- morpholinyl)-2-propen-1-one (CAS No. 110488-70-5) (provided for in subheading 2934.99.12) |
vs-99020718 |
| 9902.07.20 |
3.5% |
|
1-(4-{4-[5-(2,6-Difluorophenyl)-4,5-dihydro-1,2-oxazol- 3-yl]-1,3-thiazol-2-yl}-1-piperidinyl)-2-[5-methyl-3- (trifluoromethyl)-1H-pyrazol-1-yl]ethanone (Oxathiapiprolin) (CAS No. 1003318-67-9) (provided for in subheading 2934.99.12) |
vs-99020719 |
| 9902.07.21 |
Free |
|
(E)-{2-[6-(2-Chlorophenoxy)-5-fluoropyrimidin-4-yloxy] phenyl}(5,6-dihydro-1,4,2-dioxazin-3-yl)-N- methoxymethanimine (Fluoxastrobin) (CAS No. 361377-29-9) (provided for in subheading 2934.99.12) |
vs-99020720 |
| 9902.07.22 |
5.5% |
|
(5-Cyclopropyl-1,2-oxazol-4-yl)(α,α,α-trifluoro-2- mesyl-p-tolyl)methanone (Isoxaflutole) (CAS No. 141112-29-0) (provided for in subheading 2934.99.15). |
vs-99020721 |
| 9902.07.23 |
4.4% |
|
3-Isopropyl-1H-2,1,3-benzothiadiazin-4(3H)-one-2,2-dioxide, sodium salt (Bentazon, sodium salt) (CAS No. 50723-80-3) (provided for in subheading 2934.99.15) |
vs-99020722 |
| 9902.07.24 |
Free |
|
1-Phenyl-3-(1,2,3-thiadiazol-5-yl)urea (Thidiazuron) (CAS No. 51707-55-2) (provided for in subheading 2934.99.15) |
vs-99020723 |
| 9902.07.25 |
4.1% |
|
[3-(4,5-Dihydro-1,2-oxazol-3-yl)-4-mesyl-o-tolyl](5-hydroxy-1- methylpyrazol-4-yl)methanone (Topramezone) (CAS No. 210631-68-8) (provided for in subheading 2934.99.15) |
vs-99020724 |
| 9902.07.26 |
5.4% |
|
8-(2,6-Diethyl-4-methylphenyl)-1,2,4,5-tetrahydro-7-oxo- 7H-pyrazolo[1,2-d][1,4,5]oxadiazepin-9-yl-2,2- dimethylpropanoate (Pinoxaden) (CAS No. 243973-20-8) (provided for in subheading 2934.99.15) |
vs-99020725 |
| 9902.07.27 |
3.1% |
|
2,6-Dimethoxy-N-[3-(3-methyl-3-pentanyl)-1,2-oxazol-5- yl]benzamide (isoxaben) (CAS No. 82558-50-7) (provided for in subheading 2934.99.15) |
vs-99020726 |
| 9902.07.28 |
Free |
|
2-(2-Chlorobenzyl)-4,4-dimethyl-1,2-oxazolidin-3-one (Clomazone) (CAS No. 81777-89-1) (provided for in subheading 2934.99.15) and any formulations containing such compound (provided for in subheading 3808.93.15) |
vs-99020727 |
| 9902.07.29 |
Free |
|
Methyl [[2-chloro-4-fluoro-5[(tetrahydro-3-oxo-1H,3H-[1,3,4]thi- adiazolo[3,4-a]pyridazin-1- ylidene)amino]phenyl]thio]acetate (Fluthiacet-methyl technical) (CAS No. 117337-19-6) (provided for in subheading 2934.99.15) |
vs-99020728 |
htshub©